Clinical Trial Update: Ultra-low Dose Contrast for Endovascular Procedures

View source ↗

Summary

Clinical trial update indicating completion of a study evaluating ultra-low dose contrast for endovascular procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Critical Limb Ischemia

Snippet

Sponsor: Attikon Hospital | Conditions: Renal Impairment, Limb Ischemia, Critical | Status: COMPLETED